HOME > NEWS AND EVENTS > PRESS RELEASES LOCATIONS | CONTACT US | SITEMAP
-
News

Biomatech Offers a Full Range of Efficacy Studies for Medical Device Research and Development

9/1/2000

Biomatech, NAMSA’s French affiliate, now offers a full range of performance testing for medical device manufacturers who are interested in evaluating the efficacy of their products.  Capabilities are available within the following areas:  implantation (muscle, brain, intraocular, vascular, bone, and cartilage), including histopathological evaluation; anti-adhesion and wound healing studies; tissue and vascular grafts; corneal and ocular studies. A full array of laboratory animals is available for services offered. Technical advisors on staff (MDs, DVMs, pharmacists, and biologists) provide their combined expertise in designing and performing surgical studies.

If you have any questions about the content of this press release, contact:

Laetitia Alamercery

Biomatech - Zone Industrielle de I'Islon, 115 Rue Pasteur, 38670 Chasse-sur-Rhone, France

Phone: 33 (0)4 78 07 92 34    FAX: 33 (0)4 72 24 08 12

e-mail: info@biomatech.fr

Press release provided by:

Deborah Gibbs

NAMSA Corporate Marketing

9 Morgan, Irvine, California, 92618 USA

Phone: (949) 951-3110    FAX: (949) 454-3059

e-mail: dgibbs@namsa.com

NEED HELP?

Tell us what you need.

Or call us:

866.666.9455 (within the U.S.)
419.666.9455 (outside the U.S.)